Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$1.96 - $2.9 $29,946 - $44,309
-15,279 Reduced 39.09%
23,811 $61,000
Q4 2023

Jan 12, 2024

SELL
$1.28 - $2.85 $4,032 - $8,977
-3,150 Reduced 7.46%
39,090 $80,000
Q3 2023

Oct 13, 2023

BUY
$1.19 - $2.26 $50,265 - $95,462
42,240 New
42,240 $73,000
Q1 2022

Apr 29, 2022

SELL
$4.03 - $12.19 $42,996 - $130,055
-10,669 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$8.76 - $13.71 $119,381 - $186,839
-13,628 Reduced 56.09%
10,669 $137,000
Q3 2021

Nov 01, 2021

BUY
$6.41 - $13.54 $155,743 - $328,981
24,297 New
24,297 $262,000
Q3 2020

Nov 09, 2020

SELL
$2.63 - $8.09 $42,774 - $131,575
-16,264 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$5.69 - $8.17 $92,542 - $132,876
16,264 New
16,264 $108,000

Others Institutions Holding GRTS

About Gritstone bio, Inc.


  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.